China’s 15th Five-Year Medical Security Plan: Implications for Pharma and MedTech Strategy Through 2030

With the release of China’s National Medical Security 15th Five-Year Plan (2026-2030), the direction of healthcare security policy is coming into sharper focus. The plan serves as the sector-specific implementation framework for the broader national 15th Five-Year Plan, translating high-level medical security objectives into concrete priorities across coverage, payment, pricing, procurement, fund management, and the development of a multi-level medical security system.
This analysis provides a comprehensive strategic read of the plan, examining how these priorities fit together and what they may mean for pharmaceutical and MedTech manufacturers over the next five years.
Within that broader assessment, it focuses on three cross-cutting themes: standardization, expansion of reform reach, and more differentiated policy support for medical technology innovation and commercial insurance.
The 15th Five-Year Plan sets the strategic framework for how China’s access environment is likely to evolve through 2030. The detailed mechanisms that translate that framework into practice will continue to develop over time, shaping and reshaping manufacturers' assumptions around asset market fit, pricing, reimbursement, channel strategy, provider uptake, and partnership economics, while also creating new opportunities for targeted policy engagement.
That is where the China Access Outlook Mid-Year and Annual Strategic Debriefs come in.
They track these developments as they unfold and interpret their implications for manufacturers’ China strategy, grounded in the ongoing policy and implementation analysis delivered through Access360.
Learn more about the 2026 Mid-Year China Access Outlook: Strategic Debrief here.
Standalone purchase is available through November 30, 2026, with group pricing for teams considering 3+ licenses. The Strategic Debrief is also included with Access360 membership, along with member Q&A.
Not yet a member?
Access360 membership provides structured intelligence on China’s evolving health policy, coverage, and financing system, with member briefings, archive access, and opportunities to submit questions on published analyses.
Explore Membership